Search Results - Lydia Gaba

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Evaluation of chemotherapy-induced nausea and vomiting in low, moderate, and highly emetogenic schemes between sexes

    Evaluation of chemotherapy-induced nausea and vomiting in low, moderate, and highly emetogenic schemes between sexes by Marta Albanell‐Fernández, Ma Carmen Rodríguez Mues, Carolina Figueras, M. Altamirano, Inés Monge‐Escartín, Gisela Riu-Viladoms, Esther Carcelero San Martín, Ma Lourdes Corominas Bosch, Lydia Gaba

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix

    Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix by Inmaculada Nicolás, Adela Saco, Esther Barnadas, Lorena Marimón, Natalia Rakislova, Pere Fusté, Á. Rovirosa, Lydia Gaba, Laura Buñesch, Blanca Gil‐Ibáñez, Jaume Pahisa, Berta Díaz‐Feijoó, Aureli Torné, Jaume Ordï, Marta del Pino

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

    Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma by Aleix Prat, Alejandro Navarro, Laia Paré, Noemı́ Reguart, Patricia Galván, Tomás Pascual, Alex Martínez‐Martí, Paolo Nucíforo, Laura Comerma, Lluçia Alós, Núria Pardo, S. Cedrés, Cheng Fan, Joel S. Parker, Lydia Gaba, Iván Victoria, Núria Viñolas, Ana Vivancos, Ana Arance, Enriqueta Felip

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

    Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial by Mansoor Raza Mirza, Antonio González‐Martín, Whitney A. Spannuth Graybill, David M. O’Malley, Lydia Gaba, O.W. Stephanie Yap, Eva Guerra, Peter G. Rose, Jean‐François Baurain, Sharad Ghamande, Hannelore Denys, Emily Prendergast, Carmela Pisano, Philippe Follana, Klaus Baumann, Paula Calvert, Jacob Korach, Yong Li, Izabela A. Malinowska, Divya Gupta, Bradley J. Monk

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study

    Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study by Sara Valpione, Matteo S. Carlino, Johanna Mangana, Meghan J. Mooradian, Grant A. McArthur, Dirk Schadendorf, Axel Hauschild, Alexander M. Menzies, Ana Arance, Paolo A. Ascierto, Annamaria Di Giacomo, Francesco De Rosa, James Larkin, John Park, Simone M. Goldinger, Ryan J. Sullivan, Wen Xu, Elisabeth Livingstone, Michael Weichenthal, Rajat Rai, Lydia Gaba, Georgina V. Long, Paul Lorigan

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

    Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-... by Bhavana Pothuri, Sileny Han, Dana M. Chase, Florian Heitz, Robert A. Burger, Lydia Gaba, Linda Van Le, Eva Guerra, David Bender, Jacob Korach, Noelle Cloven, Cristina Churruca, Philippe Follana, Paul DiSilvestro, Jean‐François Baurain, К. Jardon, Carmela Pisano, Ulla Peen, Johanna Mäenpää, Divya Gupta, Emeline Bacqué, Yong Li, Natalie Compton, Jenya Antonova, Bradley J. Monk, Antonio González-Martı́n

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

    Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer by Jordi Codony‐Servat, Míriam Cuatrecasas, Elena Asensio, Carla Montironi, Anna Martínez‐Cardús, Mercedes Marín‐Aguilera, C. Hörndler, Eva Martinez‐Balibrea, Michele Rubini, Pedro Jares, Òscar Reig, Iván Victoria, Lydia Gaba, Marta Martín-Richard, Vicente Alonso, P. Escudero, Carlos Fernández-Martos, Jaime Feliú, José Carlos Méndez, Miguel Méndez, Javier Gállego, Antonieta Salud, Federico Rojo, Antoni Castells, Aleix Prat, Rafael Rosell, Xabier García‐Albéniz, Jordi Camps, Joan Maurel

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types

    Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types by Laia Paré, Tomás Pascual, Elia Seguí, Cristina Teixidó, María González‐Cao, Patricia Galván, A. Rodríguez, Blanca González‐Farré, Míriam Cuatrecasas, Estela Pineda, Aureli Torné, Guillermo Crespo, Salvador Martín‐Algarra, Elisabeth Pérez-Ruíz, Òscar Reig, Margarita Viladot, Carme Font, Bárbara Adamo, María Vidal, Lydia Gaba, Montserrat Muñoz, Iván Victoria, Guillermo Mora Ruiz, Núria Viñolas, Begoña Mellado, Joan Maurel, Javier García-Corbacho, Miguel Ángel Molina‐Vila, Manel Juan, Josep M. Llovet, Noemı́ Reguart, Ana Arance, Aleix Prat

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from PRIMA/ENGOT-OV26/GOG-3012 trial

    Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from PRIMA/ENGOT-OV26/GOG-3012 trial by B.J. Monk, Maria Pilar Barretina-Ginesta, Bhavana Pothuri, Ignace Vergote, Whitney A. Spannuth Graybill, Mansoor Raza Mirza, C. C. McCormick, Domenica Lorusso, Richard G. Moore, Gilles Freyer, Roisin E. O’Cearbhaill, Florian Heitz, David M. O’Malley, Andrés Redondo, Mark S. Shahin, Christof Vulsteke, William H. Bradley, Charlotte Aaquist Haslund, Dana M. Chase, Carmela Pisano, L.L. Holman, M.J. Rubio Pérez, Paul DiSilvestro, Lydia Gaba, Thomas J. Herzog, Ilan Bruchim, Natalie Compton, L. Shtessel, Izabela A. Malinowska, Antonio González‐Martín

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

    Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer by Ignace Vergote, José Alejandro Pérez Fidalgo, Erika Hamilton, Giorgio Valabrega, Toon Van Gorp, Jalid Sehouli, David Cibula, Tally Levy, Stephen Welch, Debra L. Richardson, Eva Guerra, Giovanni Scambia, Stéphanie Henry, Pauline Wimberger, David S. Miller, Jaroslav Klát, Jerónimo Martínez, Francesco Raspagliesi, Bhavana Pothuri, Ignacio Romero, Alice Bergamini, Brian M. Slomovitz, Fabienne Schochter, Estrid Høgdall, Lorena Fariñas-Madrid, Bradley J. Monk, Dayana Michel, Michael Kauffman, Sharon Shacham, Mansoor Raza Mirza, Vicky Makker, Ignace Vergote, Toon Van Gorp, Isabelle Cadron, Annelore Barbeaux, Nathalie Cornez, Stéphanie Henry, Joseph Kerger, Debbie Debaere, Hannelore Denys, Mansoor Raza Mirza, Amit M. Oza, Lucy Gilbert, Stephen Welch, Michael Paul Kolinsky, Qi Zhou, Jing Wang, Yingjie Yang, Kaijia Tu, Li Wang, Danbo Wang, Ge Lou, Xiaojian Yan, Jiaxin Yang, David Cibula, Jaroslav Klát, Bohuslav Melichar, Michal Zikán, Klaudia Reginacova, Vít Weinberger, Jalid Sehouli, Pauline Wimberger, Dirk Bauerschlag, Fabian Trillsch, Oliver Tomé, Fabienne Schochter, Marco Johannes Battista, Bahriye Aktas, Kristina Luebbe, Mustafa Deryal, George Fountzilas, Athina Christopoulou, Christos Papadimitriou, Flora Zagouri, Limor Helpman, Tamar Safra, Tally Levy, Ilan Bruchim, Ora Rosengarten, Aviad Zick, Giorgio Valabrega, Giovanni Scambia, Giorgia Mangili, Francesco Raspagliesi, Carmela Pisano, Donata Sartori, Ugo De Giorgi, José Alejandro Pérez Fidalgo, César Gómez-Raposo, Ignacio Romero, María Iglesias, Ana Santaballa, Nerea Ancizar, Purificación Estévez, Constanza Maximiano, A. Yubero, Ana Oaknin, Eva Guerra, Lydia Gaba, Jerónimo Martínez

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

    Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial by Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, Guillermo Villacampa, Munetaka Takekuma, Ugo De Giorgi, Kristina Lindemann, Linn Woelber, Nicoletta Colombo, Linda Duska, Alexandra Léary, Ana Godoy-Ortiz, Shin Nishio, Antoine Angelergues, María Jesús Rubio, Lorena Fariñas-Madrid, Satoshi Yamaguchi, Domenica Lorusso, Isabelle Ray‐Coquard, Luís Manso, Florence Joly, Jesús Alarcón, Philippe Follana, Ignacio Romero, Coriolan Lebreton, José Alejandro Pérez Fidalgo, Mayu Yunokawa, Hanna Dahlstrand, Véronique D’Hondt, Leslie M. Randall, Sophie Abadie‐Lacourtoisie, Claudia Andreetta, Nerea Anzizar, Daiseuke Aoki, Maria-Pilar Barretina-Ginesta, Marco Johannes Battista, Charlotte Bellier, Anne Gry Bentzen, Dominique Berton, Bertrand Billemont, Line Bjørge, Maria Bjurberg, Destin Black, Alessandra Bologna, Elena Ioana Braicu, Cláudia Casanova, Radoslav Chekerov, Annick Chevalier, Juan Cueva, Bastian Czogalla, Nicolas Delanoy, Dominik Denschlag, Oscar Derke, Michael Eichbaum, Takayuki Enomoto, Carmen Esteban, Michel Fabbro, Tanja Fehm, Annamaria Ferrero, Markus C. Fleisch, Anne Floquet, Antonio Frassoldati, Lydia Gaba, Angiolo Gadducci, Yolanda García García, Elena Geuna, Eva Guerra, Lars Hanker, Anne‐Claire Hardy‐Bessard, Philipp Harter, Kosei Hasegawa, Kristina Hellman, Ana Herrero, Felix Hilpert, Dionyssios Katsaros, M. Koegel, Anthoula Koliadi, Jean‐Emmanuel Kurtz, Bjoern Lampe, Andrea Alberto Lissoni, Alain Lortholary, Giorgia Mangili, Laura Mansi, Frederik Marmé, Cara Mathews, William Mina, Shinichiro Minobe, Katherine Moxley, Shoji Nagao, Ornella Nicoletto, Koji Nishino, Hiroshi Nishio, Shin Nishio, Ana Oaknin, Michaela Onstad, Beatriz Pardo, José Alejandro Pérez Fidalgo, Carmela Pisano, Andrés Poveda, Julia Caroline Radosa

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

    Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial by Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin, Lisa Belin, Katharina Leitner, David Cibula, Hannelore Denys, Ora Rosengarten, Manuel Rodrigues, Nikolaus de Gregorio, Jerónimo Martínez, Edgar Petru, Roman Kocián, Ignace Vergote, Patricia Pautier, Barbara Schmalfeldt, Lydia Gaba, Stephan Polterauer, Marie‐Ange Mouret‐Reynier, Jalid Sehouli, Cristina Churruca, Frédèric Selle, Florence Joly, Véronique D’Hondt, Émilie Bultot-Boissier, Coriolan Lebreton, Jean‐Pierre Lotz, Rémy Largillier, Pierre-Étienne Heudel, Florian Heitz, Jean‐Emmanuel Kurtz, Sophie Abadie‐Lacourtoisie, Cyril Abdeddaim, J. Alexandre, P. Augereau, D. Avenin, M. Azémar, Nabil Baba-Hamed, Olivia Bally, Jérôme Barrière, Fernando Bazán, Dominique Berton, Nathalie Bonichon-Lamichhane, Nathalie Bonnin, Elouen Boughalem, R. Boustany Grenier, Pierre-Emmanuel Brachet, Fabien Brocard, Émilie Bultot-Boissier, Maria Cappiello-Bataller, Hélène Castanie, L. Chaigneau, Camille Chakiba, Dorothée Chocteau-Bouju, Pierre Combe, Aurélie Comte, Elodie Coquan, Cristina Costan, P. Cottu, L. Crouzet, H. Curé, Jérôme Dauba, Hussain Dawood, Laure De Cock, T. De La Motte Rouge, C. Debelleix, Catherine Delbaldo, Martin Demarchi, Marion Deslandres, Raymond Despax, Véronique D’Hondt, Anne Françoise DILLIES-LEGRAIN, A Donnadieu, C. Dubot, Jean Marc Extra, Michel Fabbro, Claire Falandry, F. Fiteni, Anne Floquet, Philippe Follana, Jean‐Sébastien Frénel, G. Freyer, D. Garbay-Decoopman, C. Gavoille, V. Girre, Laurence Gladieff, F. Goldwasser, Alain Gratet, Jean‐Christophe Grenier, Anne‐Claire Hardy‐Bessard, Pierre-Étienne Heudel, Florence Joly, A. Jouinot, Emilie Kalbacher, Marie‐Christine Kaminsky, Laurence Lancry-Lecomte, R. Largillier, Fanny Le Du, Alexandra Léary, Coriolan Lebreton

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: